Globus Medical, Inc. (GMED) Shareholders & Insider Trades

Executive TeamFinancialsSegmentsShareholders

Globus Medical shareholders at a glance

The largest holder of Globus Medical stock is BlackRock Advisors LLC, with 10.3 million shares (9.22% of the company), worth about $839.00 million as of September 25, 2026. The 10 largest holders together own 43.9%.

In Q2 2026, 625 institutional holdings reports listed 130.0 million shares worth $9.64 billion, up 18.2% in shares from Q1 2026.

Insiders reported 38 transactions in the last two years: 21 sales worth $38.94 million and no purchases. The newest one on file is from February 25, 2026 (Huller Kelly Grace, General Counsel).

Major holders as of September 25, 2026; quarterly totals from institutional holdings reports (latest Q2 2026); insider transactions on file through February 25, 2026.

GMED logo

Globus Medical, Inc.

GMEDUnited States
Healthcare

Shareholders Summary

2026Q2

Filings
625
Options Value
$39.50M
Value (excl. Options)
$9.64B
Shares (excl. Options)
130.00M

Ownership by Type

Geographic Distribution

Largest Globus Medical shareholders

HolderShares% of companyValue
BlackRock Advisors LLC10.3 million9.22%$839.0M
Janus Henderson Investors US LLC8.2 million7.33%$667.0M
Vanguard Capital Management LLC5.1 million4.57%$416.0M
Vanguard Portfolio Management LLC5.0 million4.47%$406.0M
Invesco Advisers, Inc.4.3 million3.85%$351.0M
Kayne Anderson Rudnick Investment Management LLC4.3 million3.83%$348.0M
State Street Corporation3.7 million3.32%$302.0M
Sculptor Capital LP3.0 million2.68%$244.0M
JPMorgan Investment Management, Inc.2.7 million2.45%$223.0M
Burgundy Asset Management Ltd.2.4 million2.14%$195.0M

As of September 25, 2026.

Globus Medical institutional holdings by quarter

QuarterReportsSharesValue
Q2 2026625130.0 million$9.6B
Q1 2026628110.0 million$9.4B
Q4 2025601112.0 million$9.8B
Q3 2025516120.0 million$6.9B
Q2 2025503115.0 million$6.8B
Q1 2025535110.0 million$8.1B
Q4 2024517109.0 million$9.0B
Q3 2024467111.0 million$7.9B

Shares and value held by institutions that file quarterly holdings reports (options not included).

Globus Medical insider trades

InsiderDateTitleTransactionValue
Huller Kelly GraceFeb 25, 2026General CounselConversion of Exercise of derivative security at price 43.58 per share.$871,600
Huller Kelly GraceFeb 25, 2026General CounselSale at price 94.50 per share.$1.9M
Huller Kelly GraceFeb 12, 2026General CounselConversion of Exercise of derivative security at price 45.64 per share.$456,400
Huller Kelly GraceFeb 12, 2026General CounselSale at price 87.67 per share.$876,700
Kline KyleJan 8, 2026Chief Financial OfficerConversion of Exercise of derivative security at price 51.87 per share.$186,421
Kline KyleJan 8, 2026Chief Financial OfficerSale at price 101.10 per share.$363,353
Norwalk Leslie VJan 8, 2026DirectorSale at price 101.10 per share.$202,200
Norwalk Leslie VDec 12, 2025DirectorSale at price 88.85 per share.$355,400
Paul David CDec 8, 2025Officer, Director and Beneficial OwnerConversion of Exercise of derivative security at price 25.52 per share.$877,250
Kline KyleDec 1, 2025Chief Financial OfficerConversion of Exercise of derivative security at price 53.14 - 64.44 per share.$1.1M
Kline KyleDec 1, 2025Chief Financial OfficerSale at price 90.00 per share.$1.7M
Huller Kelly GraceNov 25, 2025General CounselConversion of Exercise of derivative security at price 25.96 per share.$194,700

Newest 12 of 38 insider transactions in the last two years.

Questions and answers

Who owns the most Globus Medical stock?

BlackRock Advisors LLC, with 9.22% of the company (as of September 25, 2026). Next: Janus Henderson Investors US LLC (7.33%) and Vanguard Capital Management LLC (4.57%).

How many institutions own Globus Medical stock?

625 institutional holdings reports listed Globus Medical shares in Q2 2026, 130.0 million shares in all worth $9.64 billion.

Are Globus Medical insiders buying or selling the stock?

In the last two years insiders reported 21 sales and no purchases (38 transactions in all); the newest on file is from February 25, 2026.

Disclaimer: This analysis is for informational and educational purposes only and does not constitute financial, investment, tax, or legal advice. Data may be incomplete, delayed, or contain inaccuracies. Consult with a qualified financial advisor before making any investment decisions.
LinkedInLinkedInXXYouTubeYouTube